Peking University Cancer Hospital & Institute
3 clinical trials · 3 recruiting · OTHER
Trials by Peking University Cancer Hospital & Institute
RECRUITINGPhase 2NCT06420973
RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression
The purpose of this study is to evaluate the efficacy, safety, and quality of life scores of patients with HER2-expressing platinum-sensitive recurrent epithelial ovarian cancer...
Sponsor: Peking University Cancer Hospital & InstituteEnrolling: 541 location
Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
RECRUITINGNCT06583369
The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs
This study was a prospective, single-center randomized controlled trial. The subject of this study is to evaluate the effectiveness and safety of traditional Chinese medicine...
Sponsor: Peking University Cancer Hospital & InstituteEnrolling: 2201 location
Hand-Foot Syndrome
RECRUITINGPhase 2NCT06869213
A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the...
This study is a prospective, observational clinical study. In this study, 30 patients with resectable locally advanced esophageal squamous carcinoma will be prospectively enrolled...
Sponsor: Peking University Cancer Hospital & InstituteEnrolling: 301 location
Esophageal Cancer (EsC)